Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tom Liptrot"'
Autor:
Azad Dehghan, Tom Liptrot, Catherine O’hara, Matthew Barker-Hewitt, Daniel Tibble, Goran Nenadic
Publikováno v:
International Journal of Population Data Science, Vol 1, Iss 1 (2017)
ABSTRACT Objectives Increasing interest to use unstructured electronic patient records for research has attracted attention to automated de-identification methods to conduct large scale removal of Personal Identifiable Information (PII). PII mainly
Externí odkaz:
https://doaj.org/article/7dabde381424432fbfbbe9cfe03373c7
Autor:
Darren R. Hodgson, Paul Smith, Christopher Womack, Nicky Whalley, J. Carl Barrett, Elizabeth A. Harrington, Jonathan R. Dry, Tom Liptrot, Alan Sharpe, Roz Brant
Purpose: To develop a clinically viable gene expression assay to measure RAS/RAF/MEK/ERK (RAS–ERK) pathway output suitable for hypothesis testing in non–small cell lung cancer (NSCLC) clinical studies.Experimental Design: A published MEK function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e38b6b2aa2da9d75f034d84c089d073
https://doi.org/10.1158/1078-0432.c.6526053.v1
https://doi.org/10.1158/1078-0432.c.6526053.v1
Autor:
Darren R. Hodgson, Paul Smith, Christopher Womack, Nicky Whalley, J. Carl Barrett, Elizabeth A. Harrington, Jonathan R. Dry, Tom Liptrot, Alan Sharpe, Roz Brant
Supplemental Table 1: Design of Affymetrix and NanoString probes Supplemental Table 2: Genes included in the NanoString Codeset, including genes up- and down-regulated by MEK, Cres and KRAS signatures, plus housekeeper genes Supplemental Table 3: Cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207fe7167da4da66d1a7029df78d7ad3
https://doi.org/10.1158/1078-0432.22465527.v1
https://doi.org/10.1158/1078-0432.22465527.v1
Autor:
Tom Liptrot, N. Slevin, Timothy D. Solberg, Khong Wei Ang, John N. Lukens, Maura Kirk, Ashley Ong, Boon-Keng Kevin Teo, Alexander Lin, Samuel Swisher-McClure, David J Thomson, Peter H. Ahn
Publikováno v:
International Journal of Particle Therapy. 2:394-403
Purpose: To investigate the potential impact of anatomic change in the treatment of locally advanced oropharyngeal cancer with proton pencil beam scanning. Materials and Methods: Ten patients with locally advanced oropharyngeal cancer who previously
Autor:
Chris Chamberlain, Sarah R. Bujac, Susan Grandy, Anne-Marie Boothman, Angelo Del Parigi, Martin Karpefors, Tom Liptrot, Jennifer Sugg
Publikováno v:
Diabetes Therapy
Introduction This study aimed to determine if data mining methodologies could identify reproducible predictors of dapagliflozin-specific treatment response in the phase 3 clinical program dataset. Methods Baseline and early treatment response variabl
Autor:
Daniel Tibble, Matthew Barker-Hewitt, Catherine O'Hara, Azad Dehghan, Tom Liptrot, Goran Nenadic
Publikováno v:
International Journal of Population Data Science. 1
ObjectivesIncreasing interest to use unstructured electronic patient records for research has attracted attention to automated de-identification methods to conduct large scale removal of Personal Identifiable Information (PII). PII mainly include ide
Autor:
Alaaeldin Shablak, Tom Liptrot, Elizabeth Keene, Rebecca Leach, J. Shanks, Robert E. Hawkins, Shien Chow, Fiona C Thistlethwaite, Manon Pillai, Andrea Spencer-Shaw, Victoria Galvis
Publikováno v:
Chow, S, Galvis, V, Pillai, M, Leach, R, Keene, E, Spencer-Shaw, A, Shablak, A, Shanks, J, Liptrot, T, Thistlethwaite, F & Hawkins, R 2016, ' High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome ', Journal for ImmunoTherapy of Cancer, vol. 4, no. 67 . https://doi.org/10.1186/s40425-016-0174-5
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background VEGF-targeted therapy has become the mainstay of treatment for majority of mRCC patients. For most patients, benefit is short-lived and therefore treatment remains palliative in intent. HD IL2 is an effective immunotherapy treatment capabl
Autor:
J. Carl Barrett, Tom Liptrot, Paul D. Smith, Nicky Whalley, Roz Brant, Darren Hodgson, Jonathan R. Dry, Elizabeth A. Harrington, Alan Sharpe, Christopher Womack
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(6)
Purpose: To develop a clinically viable gene expression assay to measure RAS/RAF/MEK/ERK (RAS–ERK) pathway output suitable for hypothesis testing in non–small cell lung cancer (NSCLC) clinical studies. Experimental Design: A published MEK functio
Publikováno v:
Natural Language Processing and Information Systems ISBN: 9783319417530
NLDB
NLDB
A patient’s occupation is an important variable used for disease surveillance and modeling, but such information is often only available in free-text clinical narratives. We have developed a large occupation dictionary that is used as part of both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c63b4a9eaa32f3066e62876a588b6ea1
https://doi.org/10.1007/978-3-319-41754-7_35
https://doi.org/10.1007/978-3-319-41754-7_35
Publikováno v:
Journal of Revenue and Pricing Management. 11:596-606
We consider a vendor selling a combined offer of multiple product types plus delivery, where delivery capacity is limited. Delivery occurs in batches each containing only a single product type. This situation occurs for fuel wholesalers who deliver t